Download FREE Report Sample
Download Free sampleBinge Eating Disorder Treatment Market contains market size and forecasts of Binge Eating Disorder Treatment in Global, including the following market information:
Global Binge Eating Disorder Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Binge Eating Disorder Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Binge Eating Disorder Treatment include Chronos Therapeutics, Shire US Inc. (part of Takeda Pharmaceutical Company), Eli Lilly and Company, Sunovion Pharmaceuticals Inc, Promises Behavioral Health, Pyramid Healthcare (Tapestry Eating Disorder Services), Timberline Knolls, Rosewood Centers for Eating Disorders and Walden Behavioral Care, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Binge Eating Disorder Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Binge Eating Disorder Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Binge Eating Disorder Treatment Market Segment Percentages, by Type, 2021 (%)
Medication
Services
Global Binge Eating Disorder Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Binge Eating Disorder Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Global Binge Eating Disorder Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Binge Eating Disorder Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Binge Eating Disorder Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Binge Eating Disorder Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Chronos Therapeutics
Shire US Inc. (part of Takeda Pharmaceutical Company)
Eli Lilly and Company
Sunovion Pharmaceuticals Inc
Promises Behavioral Health
Pyramid Healthcare (Tapestry Eating Disorder Services)
Timberline Knolls
Rosewood Centers for Eating Disorders
Walden Behavioral Care
Roche
Opiant Pharmaceuticals
Heptares
Novo Nordisk
Omeros Corp
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy